Literature DB >> 22538172

Predictors of methadone program non-retention for opioid analgesic dependent patients.

Joseph Cox1, Robert Allard, Emilie Maurais, Noreen Haley, Chris Small.   

Abstract

This study evaluates loss to follow-up in a methadone maintenance treatment (MMT) program for patients dependent on opioid analgesics in a community in eastern Canada. Data were collected using the Addiction Severity Index Lite. The probability of loss to follow-up was evaluated using a time-to-event analysis. Involuntary and voluntary program discharges were treated separately as the outcomes of interest. Multivariate Cox proportional hazards models were used to explore the role of various patient-related attributes. The probabilities of involuntary and voluntary discharges at 1 year were 20% and 14%, respectively. In this exploratory analysis, determinants of loss to follow-up were characteristics related to drug use history (e.g., use of sedatives) and its consequences (e.g., number of lifetime arrests), and differed for each outcome. Some determinants of involuntary discharge were modified by sex. Understanding predictors of specific loss to follow-up outcomes may help MMT programs improve patient retention. Crown
Copyright © 2013. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22538172     DOI: 10.1016/j.jsat.2012.03.002

Source DB:  PubMed          Journal:  J Subst Abuse Treat        ISSN: 0740-5472


  10 in total

Review 1.  Review: Sex-Based Differences in Treatment Outcomes for Persons With Opioid Use Disorder.

Authors:  Andrew S Huhn; Meredith S Berry; Kelly E Dunn
Journal:  Am J Addict       Date:  2019-05-26

2.  Retention in medication-assisted treatment programs in Ukraine-Identifying factors contributing to a continuing HIV epidemic.

Authors:  Kostyantyn Dumchev; Sergii Dvoryak; Olena Chernova; Olga Morozova; Frederick L Altice
Journal:  Int J Drug Policy       Date:  2017-08-08

3.  Psychological and physiological stress negatively impacts early engagement and retention of opioid-dependent individuals on methadone maintenance.

Authors:  Kellie M Jaremko; Robert C Sterling; Elisabeth J Van Bockstaele
Journal:  J Subst Abuse Treat       Date:  2014-08-29

4.  Demographic and clinical factors predicting retention in methadone maintenance: results from an Irish cohort.

Authors:  C D Darker; J Ho; G Kelly; L Whiston; J Barry
Journal:  Ir J Med Sci       Date:  2015-05-31       Impact factor: 1.568

5.  Analysis of genetic and clinical factors associated with buprenorphine response.

Authors:  Richard C Crist; Rachel Vickers-Smith; Rachel L Kember; Christopher T Rentsch; Heng Xu; E Jennifer Edelman; Emily E Hartwell; Kyle M Kampman; Henry R Kranzler
Journal:  Drug Alcohol Depend       Date:  2021-08-28       Impact factor: 4.852

6.  Impact of Current Pain Status on Low-Barrier Buprenorphine Treatment Response Among Patients with Opioid Use Disorder.

Authors:  Kelly R Peck; Taylor A Ochalek; Joanna M Streck; Gary J Badger; Stacey C Sigmon
Journal:  Pain Med       Date:  2021-05-21       Impact factor: 3.750

7.  Addressing the growing opioid and heroin abuse epidemic: a call for medical school curricula.

Authors:  Madison C Ratycz; Thomas J Papadimos; Allison A Vanderbilt
Journal:  Med Educ Online       Date:  2018-12

8.  Retention of patients in opioid substitution treatment: A systematic review.

Authors:  Aisling Máire O'Connor; Gráinne Cousins; Louise Durand; Joe Barry; Fiona Boland
Journal:  PLoS One       Date:  2020-05-14       Impact factor: 3.240

9.  Who stays in medication treatment for opioid use disorder? A national study of outpatient specialty treatment settings.

Authors:  Noa Krawczyk; Arthur Robin Williams; Brendan Saloner; Magdalena Cerdá
Journal:  J Subst Abuse Treat       Date:  2021-02-18

10.  Comparative effectiveness of buprenorphine-naloxone versus methadone for treatment of opioid use disorder: a population-based observational study protocol in British Columbia, Canada.

Authors:  Micah Piske; Trevor Thomson; Emanuel Krebs; Natt Hongdilokkul; Julie Bruneau; Sander Greenland; Paul Gustafson; M Ehsan Karim; Lawrence C McCandless; Malcolm Maclure; Robert W Platt; Uwe Siebert; M Eugenia Socías; Judith I Tsui; Evan Wood; Bohdan Nosyk
Journal:  BMJ Open       Date:  2020-09-09       Impact factor: 2.692

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.